Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00675_DB06708_nanopub.RAVA0D96U2jgBkcGyqzE9b8MWc5ygmCq-u18WQXWW95zI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00675_DB06708 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00675_DB06708 label "DDI between Tamoxifen and Lumefantrine - Lumefantrine, a moderate CYP2D6 inhibitor, may decrease the formation of highly potent tamoxifen metabolites. Concomitant therapy may decrease the effectiveness of tamoxifen. Consider alternate therapy. [drugbank_resource:DB00675_DB06708]" assertion.
- drugbank_resource:DB00675_DB06708 identifier "drugbank_resource:DB00675_DB06708" assertion.
- drugbank_resource:DB00675_DB06708 title "DDI between Tamoxifen and Lumefantrine - Lumefantrine, a moderate CYP2D6 inhibitor, may decrease the formation of highly potent tamoxifen metabolites. Concomitant therapy may decrease the effectiveness of tamoxifen. Consider alternate therapy." assertion.
- drugbank:DB00675 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00675_DB06708 assertion.
- drugbank:DB06708 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00675_DB06708 assertion.